Biora Therapeutics, Inc.
BIORDelisted Jun 4, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001580063
Biora Therapeutics, Inc. was delisted on Jun 4, 2025; its insiders filed their last Form 4 on Dec 16, 2024; 21 institutions reported holding it in 13F filings for Q3 2024, worth $6.13M in total; no superinvestor held it.
Q1 2024 vs. Q4 2023
How the institutions holding Biora Therapeutics, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 30 | 28 | −2 |
| Shares | 11.9M | 12.1M | +150.3K (+1.3%) |
| Value | $16.1M | $13.3M | −$2.81M (−17.5%) |
New holders (5)
Institutions that held Biora Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 17,778 | $19.6K | 0.00% |
| Leonard Rickey Investment Advisors P.L.L.C. | 16,362 | $18.0K | 0.00% |
| Clearstead Advisors, LLC | 144 | $107 | 0.00% |
| Royal Bank of Canada | 78 | $0 | 0.00% |
| CWM, LLC | 8 | $0 | 0.00% |
Sold out (7)
Institutions that held Biora Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Susquehanna International Group, LLP | 50,849 | $68.6K |
| Engineers Gate Manager LP | 15,085 | $20.4K |
| UBS Group AG | 6,146 | $8.30K |
| Qube Research & Technologies Ltd | 100 | $135 |
| FMR LLC | 80 | $108 |
| JPMorgan Chase & Co | 19 | $26 |
| Bank of America Corp | 14 | $18 |